Woodline Partners LP Dexcom Inc Transaction History

Woodline Partners LP

$19.5 Billion
Q3 2025

A detailed history of Woodline Partners LP transactions in Dexcom Inc stock. As of the latest transaction made, Woodline Partners LP holds 480,814 shares of DXCM stock, worth $27.9 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

480,814

Previous 478,399 0.5%

Holding current value

$27.9 Million

Previous $41.8 Million 22.52%

% of portfolio

0.17%

Previous 0.24%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$66.46 - $89.53 $160,500 - $216,214	2,415 Added 0.5%	480,814 $32.4 Million
Q2 2025 Aug 14, 2025	BUY	$59.83 - $87.57 $159,686 - $233,724	2,669 Added 0.56%	478,399 $41.8 Million
Q1 2025 May 15, 2025	SELL	$67.74 - $90.75 $22.9 Million - $30.7 Million	-338,692 Reduced 41.59%	475,730 $32.5 Million
Q4 2024 Feb 14, 2025	BUY	$65.68 - $81.01 $53.5 Million - $66 Million	814,422 New	814,422 $63.3 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $15.3 Million - $19.5 Million	-138,996 Reduced 62.39%	83,798 $9.5 Million

Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $1.1 Million - $1.34 Million	-9,594 Reduced 4.13%	222,794 $30.9 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $15.3 Million - $25.1 Million	-202,309 Reduced 46.54%	232,388 $28.8 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $19.9 Million - $31.8 Million	230,668 Added 113.06%	434,697 $40.6 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $21.4 Million - $25 Million	190,697 Added 1430.37%	204,029 $26.2 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $11.1 Million - $13.2 Million	-107,125 Reduced 88.93%	13,332 $1.55 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $2.26 Million - $3.26 Million	-26,597 Reduced 18.09%	120,457 $13.6 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $867,259 - $1.07 Million	-11,359 Reduced 7.17%	147,054 $11.8 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $10.8 Million - $21.1 Million	158,413 New	158,413 $11.8 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $94,080 - $130,199	-1,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $3.1 Million - $3.89 Million	-23,889 Reduced 95.98%	1,000 $537,000
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $2.66 Million - $3.56 Million	24,889 New	24,889 $13.6 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $2.78 Million - $3.43 Million	-32,748 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $1.96 Million - $2.62 Million	25,087 Added 327.46%	32,748 $12.1 Million
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $519,096 - $613,883	-5,435 Reduced 41.5%	7,661 $3.16 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $252,600 - $424,520	-4,030 Reduced 23.53%	13,096 $5.31 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $1.64 Million - $2.6 Million	-34,335 Reduced 66.72%	17,126 $4.61 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $1.88 Million - $2.95 Million	51,461 New	51,461 $11.3 Million

Others Institutions Holding DXCM

# of Institutions

1,085

Shares Held

376M

Call Options Held

6.76M

Put Options Held

7.24M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Dexcom Inc Transaction History